The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the condensed consolidated
financial statements and the notes to those statements included elsewhere in
this Quarterly Report on Form 10-Q, and with the consolidated financial
statements and management's discussion and analysis of our financial condition
and results of operations in our Annual Report on Form 10-K for our fiscal year
ended August 28, 2020 (our "Annual Report"). This discussion contains forward
looking statements that involve risks and uncertainties. Our actual results
could differ materially from those contained in these forward-looking statements
due to a number of factors, including those discussed under the caption "Risk
Factors" in our Annual Report and elsewhere in this report. See also "Cautionary
Note Regarding Forward-Looking Statements" at the beginning of this report.

Overview



SMART is comprised of business units that are leading designers
and manufacturers of electronic products focused on computing and memory
technology. The company specializes in application-specific product development
and support for customers in enterprise, government and original equipment
manufacturer, or OEM, sales channels. Customers rely on SMART businesses as
their strategic suppliers with top tier customer service, product quality, and
technical support with engineering, sales, manufacturing, supply chain and
logistics capabilities worldwide. The company supports customers in markets such
as communications, storage, networking, mobile, industrial automation,
industrial internet of things, government, military, and computing including
edge and high performance computing.  SMART operates in three segments:
Specialty Memory products, Brazil products and Specialty Compute and Storage
Solutions, or SCSS.

Recent Developments - COVID 19



The outbreak of coronavirus disease 2019 ("COVID-19") has resulted in several
millions of infections and over one and a half million deaths worldwide, as of
the date of filing of this Quarterly Report, and continues to spread in the
United States, Asia, Europe and Brazil, the major markets in which we operate.
The COVID-19 pandemic has resulted in significant governmental measures being
implemented to control the spread of the virus, and our operations as well as
the operations of our suppliers, customers and third-party sales representatives
and distributors have been and will continue to be disrupted by varying
individual and governmental responses to COVID-19 around the world such as
business shutdowns, stay-at-home directives, travel restrictions, border
closures, and other travel or health-related restrictions as well as by
absenteeism, quarantines, self-isolations, office and factory closures, delays
on deliveries, and disruptions to ports and other freight infrastructure. These
restrictions have caused consumers and businesses to reduce their activities and
their spending, have caused a slowdown in the global economy and have had, and
may continue to have, a negative impact on our sales and marketing, and our
product development activities. While we have not yet experienced a significant
disruption of our operations as a result of the COVID-19 pandemic, the pandemic
has resulted in reduced sales volumes of certain product lines within our SCSS
business in the second half of fiscal 2020 as well as in the first quarter of
fiscal 2021, and if these conditions continue, or if we have an outbreak in any
of our facilities, such reduced sales volumes may continue or worsen and we may,
among other issues, experience, in any or all product lines, delays in product
development, a decreased ability to support our customers, disruptions in sales
and manufacturing activities and overall reduced productivity each of which
could have a negative impact on our ability to meet customer commitments and on
our revenue and profitability.



                                       40

--------------------------------------------------------------------------------





Results of Operations

The following is a summary of our results of operations for the three months ended November 27, 2020 and November 29, 2019:





                                                               Three Months Ended
                                        November 27,             % of            November 29,        % of
                                            2020                sales*               2019           sales*
                                            (in thousands, other than percentages and per share data)
Consolidated Income Statements:
Net sales                            $          291,697               100 %     $      272,018           100 %
Cost of sales (1)(2)                            239,053                82 %            217,698            80 %
Gross profit                                     52,644                18 %             54,320            20 %
Operating expenses:
Research and development (1)                      6,964                 2 %             14,886             5 %
Selling, general and
administrative (1) (2)                           38,056                13 %             33,553            12 %
Total operating expenses                         45,020                15 %             48,439            18 %
Income from operations                            7,624                 3 %              5,881             2 %
Other income (expense):
Interest expense, net                            (3,154 )              (1 %)            (4,492 )          (2 %)
Other income (expense), net                         832                 0 %               (840 )           0 %
Total other expense                              (2,322 )              (1 %)            (5,332 )          (2 %)
Income before income taxes                        5,302                 2 %                549             0 %
Provision for income taxes                        3,275                 1 %                325             0 %
Net income                           $            2,027                 1 %     $          224             0 %

Earnings per share:
Basic                                $             0.08                         $         0.01
Diluted                              $             0.08                         $         0.01
Shares used in computing earnings
per share:
Basic                                            24,561                                 23,713
Diluted                                          25,103                                 24,286

* Summations may not compute precisely due to rounding.



(1) Includes share-based compensation expense as follows:
Cost of sales                        $              838                         $          730
Research and development                            778                                    744
Selling, general and
administrative                                    9,472                                  4,482
(2) Includes amortization of intangible assets expense as follows:
Cost of sales                        $              647                         $          647
Selling, general and
administrative                                    2,766                                  2,766



Three Months Ended November 27, 2020 as Compared to the Three Months Ended November 29, 2019

Net Sales



Net sales increased by $19.7 million, or 7.2%, during the three months ended
November 27, 2020 compared to the same period in the prior year. Net sales were
positively impacted by higher Specialty Memory product sales of $17.1 million,
or 16.5%, primarily due to higher Flash and DRAM revenue resulting from higher
average selling prices of 32% and 31%, respectively, mainly due to increased OEM
sales as well as a change in product mix. In addition, our sales of Brazil
products increased by $11.2 million, or 11.9%, primarily due to 98% higher
average selling prices for mobile memory. The increases in Specialty and Brazil
were partially offset by lower revenue from SCSS of $8.6 million, or 11.6%,
primarily attributable to lower Penguin revenue, which was in turn primarily due
to lower federal spending as a result of the global COVID-19 pandemic.

Cost of Sales



Cost of sales increased by $21.4 million, or 9.8%, during the three months ended
November 27, 2020 compared to the same period in the prior year, primarily due
to higher cost of materials of $20.4 million or 11.1%, due to the higher level
of sales, as well as higher production costs related to the increased revenue.
Included in the cost of sales changes was a favorable foreign exchange impact of
$2.5 million due to locally sourced cost of sales in Brazil.

Gross Profit



Gross margin decreased to 18.0% during the three months ended November 27, 2020
compared to 20.0% for the same period in the prior year, primarily due to higher
material costs for our Specialty Memory and Brazil products.

                                       41

--------------------------------------------------------------------------------

Research and Development Expense



Research and development ("R&D") expense decreased $7.9 million, or 53.2%,
during the three months ended November 27, 2020 compared to the same period in
the prior year, due to $7.9 million of Brazil financial credits resulting from
amendments to the IT law implemented in April 2020. For additional information,
see Note 1(i) in our Notes to Unaudited Condensed Consolidated Financial
Statements. Included in the R&D expense increase was an unfavorable foreign
exchange impact of $2.0 million.

Selling, General and Administrative Expense



Selling, general and administrative ("SG&A") expense increased by $4.5 million,
or 13.4%, during the three months ended November 27, 2020 compared to the same
period in the prior year, primarily due to $5.0 million higher share-based
compensation expense resulting from awards acceleration. For additional
information, see Note 9 in our Notes to Unaudited Condensed Consolidated
Financial Statements. Included in the SG&A expense increase was a favorable
foreign exchange impact of $0.6 million.

Other Income (Expense)



Interest expense, net decreased $1.3 million, or 29.8%, during the three months
ended November 27, 2020 compared to the same period in the prior year, primarily
due to lower interest expense resulting from the issuance of our convertible
senior notes and the extinguishment of our term loans in the second quarter of
fiscal 2020. For additional information, see Note 7 in our Notes to Unaudited
Condensed Consolidated Financial Statements. Other income (expense), net
increased by $1.7 million primarily due to foreign currency gains.

Provision for Income Taxes



Income tax expense includes a provision for federal, state and foreign taxes
based on the annual estimated effective tax rate applicable to SMART, adjusted
for certain discrete items which are fully recognized in the period they occur.

Provision for income taxes increased by $3.0 million for the three months ended
November 27, 2020 compared to the same period in the prior year, primarily due
to the profits and related taxes in non-U.S. jurisdictions.

As of November 27, 2020, SMART has a full valuation allowance for our net deferred tax assets associated with our U.S. operations. The amount of the deferred tax asset considered realizable could be adjusted if significant positive evidence increases.



Determining the consolidated provision for income tax expense, income tax
liabilities and deferred tax assets and liabilities involves judgment. SMART
calculates and provides for income taxes in each of the tax jurisdictions in
which it operates, which involves estimating current tax exposures as well as
making judgments regarding the recoverability of deferred tax assets in each
jurisdiction. The estimates used could differ from actual results, which may
have a significant impact on operating results in future periods.

Liquidity and Capital Resources





                                                               Three Months Ended
                                                         November 27,       November 29,
                                                             2020               2019
                                                                 (in thousands)
Cash provided by operating activities                   $       35,569     $       25,267
Cash used in investing activities                              (14,628 )           (5,116 )
Cash used in financing activities                                 (378 )           (4,047 )
Effect of exchange rate changes on cash and cash
equivalents                                                     (7,277 )           (2,854 )
Net increase in cash and cash equivalents               $       13,286     $       13,250

At November 27, 2020, we had cash and cash equivalents of $164.1 million, of which approximately $119.3 million was held outside of the United States.



In February 2020, we issued $250.0 million in aggregate principal amount of
2.25% convertible senior notes due 2026 for which we received proceeds of $243.1
million, net of issuance costs. We used $204.9 million for extinguishment of
long-term debt and $21.8 million for purchasing privately-negotiated capped
calls. For additional information, see Note 7 in our Notes to Unaudited
Condensed Consolidated Financial Statements.

We expect that our existing cash and cash equivalents, line of credit and cash
generated by operating activities will be sufficient to fund our operations for
at least the next twelve months. Our principal uses of cash and capital
resources are acquisitions, debt service requirements as described below,
capital expenditures, R&D expenditures and working capital requirements. We
expect that future capital expenditures will focus on expanding capacity of our
operations, expanding our R&D activities, manufacturing

                                       42

--------------------------------------------------------------------------------


equipment upgrades, acquisitions and IT infrastructure and software upgrades.
Cash and cash equivalents consist of funds held in demand deposit accounts and
money market funds. We do not enter into investments for trading or speculative
purposes.

During the three months ended November 27, 2020, cash provided by operating
activities was $35.6 million. The primary factors affecting our cash flows
during this period were $23.3 million of non-cash related expenses, $10.3
million change in our net operating assets and liabilities, and $2.0 million of
net income. The $10.3 million change in net operating assets and liabilities
consisted of increases of $1.9 million in accounts receivable and $9.3 million
in prepaid expenses and other assets, and decreases of $1.5 million of operating
lease liabilities and $7.9 million in accrued expense and other liabilities,
offset by decreases of $12.9 million in inventory and an increase of $18.0
million of accounts payable. The increase in accounts receivable was primarily
due to timing of sales, and the increase in accounts payable was primarily due
to timing of payments. The decrease in inventory was primarily due to better
efficiencies in managing our inventory along all business areas.

During the three months ended November 29, 2019, cash provided by operating
activities was $25.3 million. The primary factors affecting our cash flows
during this period were $0.2 million of net income, $16.4 million of non-cash
related expenses and a $8.6 million change in our net operating assets and
liabilities. The $8.6 million change in net operating assets and liabilities
consisted of increases of $13.7 million in accounts receivable and $42.2 million
in inventory, and a decrease of $1.1 million of operating lease liabilities,
offset by a decrease of $5.1 million in prepaid expenses and other assets and
increases of $60.4 million of accounts payable and $0.1 million in accrued
expense and other liabilities. The increase in accounts receivable was primarily
due to timing of sales, while the increases in inventory and accounts payable
were primarily due to the transition of inventory from contract manufacturers to
the company due to our recent acquisitions, as well as higher purchases for
certain programs.

Net cash used in investing activities during the three months ended November 27,
2020 was $14.6 million consisting primarily of purchases of property and
equipment and deposits. Net cash used in investing activities during the three
months ended November 29, 2019 was $5.1 million consisting primarily of
purchases of property and equipment and deposits.

Net cash provided by financing activities during the three months ended November
27, 2020 was $0.4 million, consisting primarily of $3.5 million for withholding
tax on restricted stock units, partially offset by $3.1 million proceeds from
issuance of ordinary shares from share option exercises and employee share
purchase plans. Net cash used in financing activities during the three months
ended November 29, 2019 was $4.0 million, consisting primarily of $6.4 million
long-term debt payments for both the Amended Credit Agreement and the BNDES
Credit Agreement, partially offset by $2.4 million proceeds from issuance of
ordinary shares from share option exercises and employee share purchase plans.

There have been no material changes to contractual obligations previously disclosed in our Annual Report.

Off-Balance Sheet Arrangements



We do not have any relationships with unconsolidated entities or financial
partnerships, such as entities often referred to as structured finance or
special purpose entities, which would have been established for the purpose of
facilitating off-balance sheet arrangements or other contractually narrow or
limited purposes. In addition, we do not have any undisclosed borrowings or
debt, and we have not entered into any synthetic leases. We are, therefore, not
materially exposed to any financing, liquidity, market or credit risk that could
arise if we had engaged in such relationships.

We do not have any off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial conditions, net sales or expenses, results of operations, liquidity,
capital expenditures or capital resources that is material to investors.

Recent Accounting Pronouncements



See Note 1 of our Notes to Unaudited Condensed Consolidated Financial Statements
for information regarding the effect of recent accounting pronouncements on our
financial statements.

Critical Accounting Policies



The preparation of financial statements and related disclosures in conformity
with accounting principles generally accepted in the United States of America
("U.S. GAAP") requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting period. On an ongoing
basis, we evaluate our estimates, including those listed below. We base our
estimates on historical facts and various other assumptions that we believe to
be reasonable at the time the estimates are made. Actual results could differ
from those estimates.

Our critical accounting policies are as follows:



  • Revenue recognition;


  • Inventory valuation;


                                       43

--------------------------------------------------------------------------------





  • Income taxes;


  • Goodwill valuation;

• Impairment of long-lived assets and long-lived assets to be disposed; and

• Share-based compensation.




Our critical accounting policies are important to the portrayal of our financial
condition and results of operations, and require us to make judgments and
estimates about matters that are inherently uncertain. There have been no
material changes to our critical accounting policies and estimates disclosed in
"Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations-Critical Accounting Policies and Estimates" and Note 1, Overview,
Basis of Presentation and Significant Accounting Policies, in each case in our
Annual Report.

© Edgar Online, source Glimpses